Multiple Manufacturers

OCTREOTIDE ACETATE

Manufacturer:

Multiple Manufacturers

Octreotide Acetate HCPCS:

J2354

HCPCS Code Descriptor:

Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg

Category:

J Code

Octreotide Acetate NDCs:

00078-0182-01, 62756-0352-40, 62756-0351-44, 63323-0377-01, 63323-0379-05, 25021-0465-01, 25021-0453-01, 00641-6176-10, 23155-0689-41, 23155-0686-31, 67457-0246-01, 00078-0181-01, 25021-0455-05, 00641-6178-01, 63323-0377-04, 00078-0180-01, 00078-0182-61, 62756-0350-40, 62756-0349-44, 62756-0094-44, 63323-0378-05, 63323-0376-01, 23155-0685-31, 25021-0454-05, 00641-6177-01, 67457-0245-01, 25021-0464-01, 25021-0452-01, 00641-6175-10, 23155-0688-41, 62756-0348-44, 63323-0365-01, 23155-0687-41, 25021-0451-01, 00641-6174-10, 25021-0463-01, 67457-0239-01, 63323-0376-04, 00078-0181-61, 63323-0365-04, 00078-0180-61

Primary Type:

Growth Disorder

Generic/Specialty Status:

Multi-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

62756-0352-40, 62756-0351-44, 25021-0453-01, 25021-0455-05, 62756-0350-40, 62756-0349-44, 62756-0094-44, 25021-0454-05, 25021-0452-01, 62756-0348-44, 63323-0365-01, 25021-0451-01, 63323-0365-04

About Octreotide Acetate:

OCTREOTIDE ACETATE is a Growth Disorder drug manufactured by Teva and administered via the Injection route of administration. The J Code: J2354 is aligned to the drug OCTREOTIDE ACETATE.

ACCESS PRICING AND MORE BY REGISTERING

J2354 Added Date:

January 1, 2004

J2354 Effective Date:

January 1, 2004

J2354 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Octreotide Acetate billing and coding information.
Octreotide Acetate patient assistance information can be found through Novartis Patient Support at the URL: https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment
OCTREOTIDE ACETATE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for OCTREOTIDE ACETATE. Please check back in a few weeks.